| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |